MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
作者： Jeffrey A Engelman , Kreshnik Zejnullahu , Tetsuya Mitsudomi , Youngchul Song , Courtney Hyland
DOI: 10.1016/S1040-1741(08)79219-4
关键词:
摘要: … MET signaling underlies the acquired resistance to gefitinib, we examined whether MET inhibition suppressed growth of the resistant … -665752, a MET tyrosine kinase inhibitor, alone or …
elsevier.com 
sci-hub.se 参考文章(3)
J. A. Engelman, K. Zejnullahu, T. Mitsudomi, Y. Song, C. Hyland, J. O. Park, N. Lindeman, C.-M. Gale, X. Zhao, J. Christensen, T. Kosaka, A. J. Holmes, A. M. Rogers, F. Cappuzzo, T. Mok, C. Lee, B. E. Johnson, L. C. Cantley, P. A. Janne, MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling Science. ,vol. 316, pp. 1039- 1043 ,(2007) , 10.1126/SCIENCE.1141478
Gerold Bepler, Irina Kusmartseva, Swati Sharma, Ashish Gautam, Alan Cantor, Anupama Sharma, George Simon, RRM1 Modulated In Vitro and In Vivo Efficacy of Gemcitabine and Platinum in Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 24, pp. 4731- 4737 ,(2006) , 10.1200/JCO.2006.06.1101
Federico Cappuzzo, Claudia Ligorio, Pasi A. Jänne, Luca Toschi, Elisa Rossi, Rocco Trisolini, Daniela Paioli, Alison J. Holmes, Elisabetta Magrini, Giovanna Finocchiaro, Stefania Bartolini, Alessandra Cancellieri, Fortunato Ciardiello, Marco Patelli, Lucio Crino, Marileila Varella-Garcia, Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial Journal of Clinical Oncology. ,vol. 25, pp. 2248- 2255 ,(2007) , 10.1200/JCO.2006.09.4300